Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: 2024 Tirzepatide-Bariatric Surgery [Phase 4]

View source ↗

Summary

Phase 4 study evaluating tirzepatide in combination with bariatric surgery; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)

Snippet

Sponsor: Marlene Starr | Conditions: Obesity and Obesity-related Medical Conditions, Bariatric Surgery | Phase 4 | Status: RECRUITING